Unnecessary Cervical Epidural Injection in An Octogenarian.
Cervical
Defibrillator
Epidural injections
Five cardiac stents
Octogenarian
Unnecessary
Journal
Surgical neurology international
ISSN: 2229-5097
Titre abrégé: Surg Neurol Int
Pays: United States
ID NLM: 101535836
Informations de publication
Date de publication:
2019
2019
Historique:
received:
12
03
2019
accepted:
14
03
2019
entrez:
19
9
2019
pubmed:
19
9
2019
medline:
19
9
2019
Statut:
epublish
Résumé
Epidural spine injections (ESI) have no documented long-term efficacy. Furthermore, cervical ESI uniquely risk intramedullary injections with resultant neurological deficits (e.g. monoplegia to quadriplegia), and intravascular vertebral injections (e.g. which potentially contribute to stroke, brain stem infarction). A patient in his mid-eighties presented with 1 year's duration of neck pain without any accompanying numbness, tingling or weakness in the upper or lower extremities. He had no radiculopathy, myelopathy, or neurological deficit. Two years earlier, the patient sustained a myocardial infarction (MI), requiring over 5 stents and a defibrillator. At the time of presentation, he was still on a baby ASA (81 mg/day), on anti-hypertensives, and cholesterol-lowering medications. His non-contrast cervical CT scan (patient had a pacemaker/defibrillator and could not have an MR) from the summer of 2018 showed no significant spinal cord or nerve root compression at any level. Nevertheless, he was subjected to two cervical epidural injections in the early fall; his baby ASA was stopped 5 days prior to each of these injections. Notably, this placed him at increased risk of MI and/or stroke. When he was seen by neurosurgery, without any neurological deficit or significant cervical radiographic findings, he was referred back to neurology for continued conservative management. Patients are increasingly subjected to epidural cervical spinal injections that have no documented long-term efficacy, and expose them to significant risks/complications. This 80+ year-old patient, without a neurological deficit or significant cervical CT-documented pathology, underwent 2 cervical ESI that unnecessarily exposed him to potential cardiac-stent related thrombosis (e.g. stopping ASA for 5 days-a bona-fide requirement for ESI to avoid acute epidural hematomas).
Sections du résumé
BACKGROUND
BACKGROUND
Epidural spine injections (ESI) have no documented long-term efficacy. Furthermore, cervical ESI uniquely risk intramedullary injections with resultant neurological deficits (e.g. monoplegia to quadriplegia), and intravascular vertebral injections (e.g. which potentially contribute to stroke, brain stem infarction).
CASE DESCRIPTION
METHODS
A patient in his mid-eighties presented with 1 year's duration of neck pain without any accompanying numbness, tingling or weakness in the upper or lower extremities. He had no radiculopathy, myelopathy, or neurological deficit. Two years earlier, the patient sustained a myocardial infarction (MI), requiring over 5 stents and a defibrillator. At the time of presentation, he was still on a baby ASA (81 mg/day), on anti-hypertensives, and cholesterol-lowering medications. His non-contrast cervical CT scan (patient had a pacemaker/defibrillator and could not have an MR) from the summer of 2018 showed no significant spinal cord or nerve root compression at any level. Nevertheless, he was subjected to two cervical epidural injections in the early fall; his baby ASA was stopped 5 days prior to each of these injections. Notably, this placed him at increased risk of MI and/or stroke. When he was seen by neurosurgery, without any neurological deficit or significant cervical radiographic findings, he was referred back to neurology for continued conservative management.
CONCLUSIONS
CONCLUSIONS
Patients are increasingly subjected to epidural cervical spinal injections that have no documented long-term efficacy, and expose them to significant risks/complications. This 80+ year-old patient, without a neurological deficit or significant cervical CT-documented pathology, underwent 2 cervical ESI that unnecessarily exposed him to potential cardiac-stent related thrombosis (e.g. stopping ASA for 5 days-a bona-fide requirement for ESI to avoid acute epidural hematomas).
Identifiants
pubmed: 31528446
doi: 10.25259/SNI-197-2019
pii: SNI-10-108
pmc: PMC6744805
doi:
Types de publication
Case Reports
Langues
eng
Pagination
108Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Tex Heart Inst J. 2010;37(3):343-6
pubmed: 20548819
Spine J. 2011 Apr;11(4):303-7
pubmed: 21474081
Heart Lung Circ. 2011 Jul;20(7):438-45
pubmed: 21493140
Ann Surg. 2012 May;255(5):811-9
pubmed: 22470078
Spine (Phila Pa 1976). 2013 Aug 15;38(18):1561-5
pubmed: 23680836
Eur Spine J. 2014 Aug;23(8):1777-82
pubmed: 24740280
Surg Neurol Int. 2015 Aug 31;6(Suppl 14):S383-7
pubmed: 26425398
Surg Neurol Int. 2017 Apr 26;8:60
pubmed: 28540126
Reg Anesth Pain Med. 2018 Apr;43(3):225-262
pubmed: 29278603
Surg Neurol Int. 2018 Apr 23;9:86
pubmed: 29740507